Gabapentin
- Product NDC
- 59115-075
- 11-digit product format
- 591150075
- Labeler code
- 59115
- Product ID
- 59115-075_644343c6-5cd6-435f-a260-0d62901b3b87
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Hikma Pharmaceutical
- Application
- ANDA078150
- Marketing category
- ANDA
- Marketing start
- 2007-07-09
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 400 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078150-001 | GABAPENTIN | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | ||
| A078150-002 | GABAPENTIN | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | ||
| A078150-003 | GABAPENTIN | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078150-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2007-09-25 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078150-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2007-09-25 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078150-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2007-09-25 | 301d65b070ca… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.